-
Marin: Study Initiated; Subject Screening Begins
-
Marin: DEA Approves Schedule I License; Study Prepares for Initiation
-
Marin: California Review Panel Approves Study Protocol, Now Awaiting DEA Approval
-
Marin: FDA Approves New Study Protocol
-
Marin: Study Protocol Submitted to FDA
-
Marin: IRB Approves Study Protocol; Submitted to FDA

